Cationic copolymers consisting of polycations linked to nonionic polymers are evaluated as non-viral gene delivery systems. These copolymers are known to produce soluble complexes with DNA, but only a few studies have characterized the transfection activity of these complexes. This work reports the synthesis and characterization of a series of cationic copolymers obtained by grafting the polyethyleneimine (PEI) with non-ionic polyethers, poly (ethylene oxide) (PEO) or Pluronic 123 (P123). The PEO-PEI conjugates differ in the molecular mass of PEI (2 kDa and 25 kDa) and the degree of modification of PEI with PEO. All of these conjugates form complexes upon mixing with plasmids, which are stable in aqueous dispersion for several days. The sizes of the particles formed in these systems vary from 70 to 200 nm depending on the composition of the complex. How-
Introduction
Non-viral gene transfer vectors based on DNA complexes with polycations have recently generated very significant interest for gene delivery applications. [1] [2] [3] Among the large number of cationic polymers described, polyethyleneimine (PEI) was shown to be a useful carrier able to condense and deliver DNA in vitro and in vivo. 4, 5 This polymer spontaneously forms interpolyelectrolyte complexes with DNA as a result of cooperative electrostatic interactions between the ammonium groups of the polycation and phosphate groups of the DNA. However, most polycations, including PEI, present a severe drawback since their complexes with DNA are often poorly soluble. 6 A promising approach for overcoming the solubility problem has recently been proposed by several investigators. [7] [8] [9] [10] [11] [12] [13] It uses a new type of cationic carrier with block or graft copolymer architecture consisting of a polycation linked to a non-ionic water-soluble polymer, for example, poly(ethylene oxide) (PEO). The complexes formed between DNA and these cationic copolymers remain in dispersion due to the effect of the nonionic chains that ever, transfection activity of these systems is much lower than that of PEI (25 kDa) or Superfect as assessed in in vitro transfection experiments utilizing a luciferase reporter expression in Cos-7 cells as a model system. In contrast, conjugate of P123 with PEI (2 kDa) mixed with free P123 (9:1(wt)) forms small and stable complexes with DNA (110 nm) that exhibit high transfection activity in vitro. Furthermore, gene expression is observed in spleen, heart, lungs and liver 24 h after i.v. injection of this complex in mice. Compared to 1,2-bis(oleoyloxy)-(trimethylammonio) propane:cholesterol (DOTAP:Chol) and PEI (25 kDa) transfection systems, the P123-PEI system reveals a more uniform distribution of gene expression between these organs, allowing a significant improvement of gene expression in liver. Gene Therapy (2000) 7, 126-138.
are soluble in water. Several systems have recently been described including PEO-b-polyspermine, 7, 11 PEO-g-PEI, 11 PEO-b-poly(L-lysine), [8] [9] [10] and PEO-g-poly(Llysine) 12 , dextran-g-poly(L-lysine) 13 and poly-N-(2-hydroxypropyl)-methacrylamide-b-poly(trimethylammoniomethyl methacrylate chloride). 8 Dispersions of complexes of DNA stable in aqueous media were obtained using these copolymers. [7] [8] [9] [10] [11] [12] [13] Furthermore, increased activity of antisense oligonucleotides incorporated into such systems was reported based on in vitro and in vivo studies. 7, 14, 15 However, few improvements of transfection activity of plasmid DNA were reported. Furthermore, these systems have not been compared with commercially available transfection agents, such as PEI, dendrimers, or cationic liposomes. 8, 12 In this work we prepared a series of cationic copolymers by grafting PEI with polyethers, PEO and Pluronic 123 (P123) and then evaluated these copolymers as delivery systems for the plasmid DNA in vitro and in vivo. At physiological conditions, PEO chains do not aggregate and do not interact with other molecules or lipid membranes. 16 In contrast, Pluronic block copolymers have a triblock structure, PEO-b-PPO-b-PEO, in which the poly(propylene oxide) (PPO) segments provide for both the self-assembly of these molecules into micelles as well as the interaction of these molecules with biological membranes. 17 Based on the previous report that Pluronic block copolymers can increase in vitro transfection with DNA/poly(N-ethyl-4-vivylpyridinium bromide) complexes, 18 these molecules appear to be worth exploring as a component in the cationic copolymers. This paper describes the preparation of the complexes between cationic copolymers and plasmid DNA, the characterization of these systems and, finally, their evaluation as transfection agents in vitro and in vivo in comparison with the previously described non-viral gene delivery systems.
Results

Cationic copolymers
Cationic copolymers were synthesized by grafting polyether chains, PEO or P123, to the amino groups of PEI. The nomenclature and characteristics of the cationic copolymers synthesized are presented in Table 1 . Low molecular mass PEI (2 kDa) and high molecular mass PEI (25 kDa) were used in this study. Both PEI samples are randomly branched and contain primary, secondary and tertiary amino groups at a ratio 1.3:1.2:1 as determined by NMR analysis. 11 In all cases, except for PEO(10K)-g-PEI(2K), free hydroxyl groups of the polyether chains were activated by 1,1Ј-carbonyldiimidazole and then linked to the amino groups of the PEI. In the case of PEO(10K)-g-PEI(2K), methoxy-PEO-glycidyl ether was used for conjugation with PEI. The copolymers were separated from unconjugated polymers by gel permeation chromatography (GPC) as described in Materials and methods, and then the ratios of the polyether and PEI chains in these samples were determined from 1 H-NMR spectra using integral values obtained for the -CH 2 CH 2 Oprotons (PEO, P123) and -CH 2 NH-protons (PEI).
The PEO-PEI copolymers synthesized can be subdivided into two groups based on the molecular mass of PEI utilized during synthesis. The first group includes two copolymers in which PEO chains are grafted to the low molecular mass PEI (2 kDa). The weight-average molecular masses (M w ) and polydispersity indexes (M w /M n ) of these copolymers were determined by GPC coupled with light scattering detector. The molecular masses were in reasonable agreement with the 1 H-NMR analysis of the content of the PEO and PEI fragments in these copolymers. According to the 1 H-NMR analysis, these copoly- Gene Therapy mers have relatively low degrees of modification varying from 2.2% to 3.6%, which corresponds to an average of 1 and 1.7 PEO chains linked to PEI (Table 1) . The second group of the PEO-PEI copolymers was based on the high molecular mass PEI (25 kDa). This group also contained two copolymers, PEO(5K) 37 -g-PEI(25K) and PEO(5K) 61 -g-PEI(25K) presented in Table 1 . The molecular masses of these copolymers, as determined by GPC light scattering technique, were at least one order of magnitude higher than those of the copolymers based on low molecular mass PEI (2 kDa) ( Table 1) . As follows from the 1 H-NMR analysis of the content of PEO and PEI fragments, the copolymers based on PEI (25 kDa) had higher degrees of modification than the copolymers based on low molecular mass PEI (2 kDa). The degrees of modification, 6.3% and 10.4%, obtained using this technique corresponded to an average of 37 and 61 PEO chains linked to PEI, for PEO(5K) 37 -g-PEI(25K) and PEO(5K) 61 -g-PEI(25K) respectively.
Finally, the P123-modified PEI (2 kDa), P123-g-PEI(2K), was synthesized (Table 1) . In aqueous solutions this copolymer alone self-assembled in micelle-like aggregates with an effective diameter of 60 to 70 nm, as revealed by photon correlation spectroscopy (data not presented). Since no aggregation was observed in 20% ethanol, the ethanol-containing buffer was used as an eluent in GPC analysis of the molecular mass of this copolymer (M GPC ). The M GPC value obtained using this technique agreed reasonably well with the NMR analysis suggesting that there is an average of 3.2 P123 chains per one PEI chain in this sample (modification degree 6.9%).
Analysis of the complexes using agarose gel electrophoresis
In this paper we use N/P ratio, ie the ratio of concentrations of total nitrogen atoms (N) of the polycation to the phosphate groups (P) of DNA, as the characteristic of the complex composition. Complexes of plasmid DNA and cationic copolymers were prepared at various N/P ratios and analyzed by agarose gel electrophoresis. An example of a typical result obtained during electrophoresis experiments for all copolymers is presented in Figure 1 . In this example, movement of the plasmid in the gel is retarded as the amount of the PEO(8K)-g-PEI(2K) copolymer is increased, demonstrating that the copolymer binds to the DNA, neutralizing its charge. At N/P ratios exceeding the neutralization composition, the complexes migrate slightly toward the anode, suggesting that they have a small positive charge (Figure 1 ). This method allows estimation of the N/P ratio which results in complete neutralization of the DNA (also termed in the literature as the 'stoichiometric composition' 6 ). For all cationic copolymers presented in Table 1 complete neutralization is achieved at N/P ratios from approximately 1.5 to 3. These results demonstrate that only 1/3 to 1/2 of the nitrogen atoms of the polycations are able to form salt bonds with the DNA phosphate groups under the conditions studied. These results are similar to the results obtained for unconjugated PEI (data not presented).
Zeta-potential measurements
Changes in the charge of the complexes upon addition of the cationic copolymers were further characterized by measurement of the zeta potential, , for various N/P ratios. Three typical examples of the results of these experiments are shown in Figure 2 for PEO(8K)-g-PEI(2K), PEO(5K) 37 -g-PEI(25K) and P123-g-PEI(2K) complexes. The zeta potential was negative at low N/P ratios (excess of phosphate groups). With increasing N/P ratio, also increased and approximated zero at N/P ranging from 2 to 3. This demonstrates progressive neutralization of the DNA phosphate groups by the charged amino groups of the polycation. At significant excess of the amino groups of the copolymers (N/P Ͼ 2 Ϭ 3), levels off at zero or a slightly positive value (Figure 2) . Thus, the zeta-potential measurements are consistent with the results of the agarose gel electrophoresis experiments.
Stability in aqueous dispersion and sizes of the complexes
Stability of the complexes of plasmid DNA and PEI homopolymers or various cationic copolymers in aqueous dispersion was evaluated by measuring the turbidity of the solution, , at different N/P ratios. The effective diameters and polydispersity indexes of the complexes were determined by photon correlation spectroscopy. The results of these studies are summarized in Table 2 . The complexes of DNA and low molecular mass PEI (2 kDa) precipitated at a broad range of N/P ratios from 0.1 to 15. Complexes formed with high molecular weight PEI (25 kDa) and DNA precipitated at N/P ratios from 0.1 to 3. However, at N/P ratios above 3, the turbidity of the solution decreased, suggesting at least partial solubilization of these complexes. The sizes of the complexes formed under these conditions were strongly dependent on the buffer used and the presence of serum as shown in Table 3 . For example, at N/P ratio 4, PEI (25 kDa)/DNA complexes were very large and polydisperse aggregates (Ͼ 300 nm) in phosphate containing buffers (10 mm phosphate, PBS, DMEM). In contrast, in 10 mm Hepes and HBS small particles (90 to 120 nm) were formed. Also, in the presence of serum small particles were formed in DMEM.
Complexes formed by DNA and PEO-modified PEI (2 kDa) or PEO-modified PEI (25 kDa) were transparent or slightly opaque in the entire range of N/P ratios from 0.1 to 15 studied in this work. The sizes of the particles formed in these systems were much less affected by the buffer used than those in the case of PEI homopolymer ( Table 3) . As is seen in Table 3 , there was a noticeable decrease in the size of the particles formed by DNA and PEO(8K)-g-PEI(2K) in the presence of serum. Complexes on the base of PEO-modified PEI (25 kDa) appeared to be the least dependent on the presence of the serum. Figure 3 presents typical dependencies of the particle size on the N/P ratio. In the case of the copolymers on the base of low molecular mass PEI (2 kDa), the particle sizes decreased slightly upon elevation of N/P ratio. In the case of copolymers of the base of high molecular mass 
Precipitates in the entire range of N/P ratios Impossible due to precipitation studied from 0.1 to 15
PEI(25K)
Precipitates at N/P ratios from 0.1 to 3. At N/P Measurements at N/P = 4 in phosphate containing ratio above 3 the turbidity decreases buffers reveals large aggregates in ( PEI (25 kDa), there was a size maximum at N/P ratio 3 (180 nm) and the sizes decreased at higher N/P ratios. (Effective diameters of the complexes formed by PEO(5K) 61 -g-PEI(25K) were practically the same as those shown in Figure 3 for the PEO(5K) 37 -g-PEI(25K) complexes.) The polydispersity indexes of all complexes formed by PEO-modified PEI (2 kDa and 25 kDa) and DNA ranged from 0.1 to 0.2 indicating relatively broad size distributions. No increases in turbidity or size changes were observed with these complexes for a period of at least a week, demonstrating high stability of these systems in aqueous dispersion.
Initial turbidity experiments on the complexes formed by DNA and Pluronic-grafted PEI, P123-g-PEI(2K), were performed with a DNA concentration of 0.2 mg/ml. At this concentration the systems were strongly turbid at all N/P ratios from 0.1 to 15. The turbidity of the solutions was not dependent on the order of mixing of the components (either concentrated DNA solution added to the polycation solution or vice versa). However, addition of non-modified P123 resulted in the decrease of turbidity (data not shown). Therefore, in further experiments, mixtures of P123-g-PEI(2K) and free P123 were used. We present here the characterization data obtained for 9:1(wt) mixture of free P123 and P123-g-PEI(2K). This composition was shown to be the most efficient in the transfection experiments (see below). The sizes of the particles formed in this system varied from approximately Gene Therapy 250 to 110 nm over a range of N/P ratios from 1 to 15 ( Figure 3 ). These systems were characterized by high polydispersity ranging from 0.2 to 0.3. At N/P ratio 2, corresponding to the electroneutral composition, the complexes precipitated overnight. However, no precipitation was observed at N/P ratios from 3 to 15 at least for several days. There was little dependence of the particle size on the buffer used (Table 3) . Particles formed in the presence of serum were significantly smaller than those formed in serum-free media (Table 3) . Generally, addition of serum appeared to stabilize these systems in all buffers, preventing aggregation of particles.
Morphology of the complexes
Complexes formed between the plasmid DNA and various cationic copolymers were characterized by negative staining electron microscopy. The N/P ratios used in these experiments corresponded to those revealing the highest activity in in vitro transfection experiments. The primary types of morphologies observed with various complexes are presented in Figure 4 . The first type shows donut-like structures with an average diameter about 100 nm ( Figure 4b ). Another type represents threads ( Figure  4c ), which are similar in shape but much thicker than the native DNA (Figure 4a ). These threads and donuts have the same thickness (approximately 20 nm) and their mixtures appeared to be typical for the complexes formed by PEO-grafted low molecular mass PEI (2 kDa). A third Complexes were prepared by adding equal volumes of polycations to DNA at N/P ratios optimal for transfection: 4 (PEI); 5(PEO(8K)-g-PEI(2K)); 3 (PEO(5K) 37 -g-PEI(25K)); 10(P123:P123-g-PEI(2K)). DNA concentration was 0.2 mg/ml (PEO(8K)-g-PEI(2K), PEO(5K) 37 -g-PEI(25K)), 0.06 mg/ml (PEI) and 0.03 mg/ml (P123:P123-g-PEI(2K)) ND, not determined. type of morphology represents dense granules which are much smaller (less than 50 nm) and fairly polydisperse (Figure 4d ). These granules have a tendency to cluster on a grid, which, however, may be a secondary phenomenon. Although the density of these structures varied slightly for copolymers with different degree of modification they appeared to be characteristic of the complexes formed by PEO-grafted high molecular mass PEI (25 kDa) . No extended threads were observed with these samples, suggesting that copolymers on the base of PEI (25 kDa) promoted stronger condensation of the DNA than those on the base of PEI (2 kDa). Finally, large (160 to 200 nm) amorphous structures were observed with the systems on the base of P123-g-PEI(2K) (Figure 4e ). These structures were of uniform size and shape. They remained either isolated from each other or formed associates of no more than three species. It is likely that such structures are composed of multiple DNA and copolymer molecules.
Figure 3 Effective diameters of the complexes formed between pGL3 plasmid and various cationic copolymers as a function of the N/P ratio: (᭺) PEO(8K)-g-PEI(2K), (ᮀ) PEO(10K)-g-PEI(2K), () PEO(5K) 37 -g-PEI(25K), and (᭹) P123-g-PEI(2K) and P123 mixture (P123:P123-g-PEI(2K) ratio 9:1 (wt)
Transfection efficiency of cationic copolymer-DNA complexes in vitro Complexes formed between plasmid DNA and the cationic copolymers were assessed for their in vitro transfection activity utilizing a transient expression of luciferase reporter in Cos-7 cells. Transfection experiments were carried out according to the described protocol, either in the presence or absence of the fetal bovine serum. The dendrimer transfecting agent, Superfect, was used in all experiments as a reference standard. For all cationic copolymers, the efficacy of transfection was dependent on the N/P ratio, as is shown in Figure 5 using P123-g-PEI(2K) system as an example. The transfection data obtained for homopolymer PEI and various cationic copolymers at optimal N/P ratio is summarized in Table  4 . The DNA/PEI (2 kDa) complexes were insoluble at all N/P ratios and, therefore, could not be examined in transfection experiments. In contrast, the DNA/PEI (25 kDa) complexes gave luciferase signals comparable to those obtained with Superfect (Table 4 ). The optimal transfection activity of PEI (25 kDa) was observed at N/P ratio of approximately 4, which is consistent with the previous report. 4 In our experiments the PEI-mediated transfection appeared to be more dependent on the presence of serum than the Superfect-mediated transfection (data not shown).
The transfection activity of the high molecular mass PEI was significantly reduced when it was grafted with the PEO chains ( Table 4 ). The DNA complexes with PEO(5K) 37 -g-PEI(25K) exhibited less that 20% efficacy when compared with the Superfect (Table 4 ). The copolymer with the highest degree of modification, PEO(5K) 61 -g-PEI(25K), was completely inactive. The complexes formed by PEO-grafted PEI (2 kDa) were also much less active than the Superfect composition. PEO(10K)-g-PEI(2K) exhibited about 10% of Superfect activity, while PEO(8K)-g-PEI(2K) was practically inactive (luciferase expression was only two-to three-fold higher than that in cells treated with the naked DNA).
The highest transfection efficiency was observed with P123-g-PEI(2K) complexes, which was the only copolymer system producing luciferase signals exceeding those obtained with Superfect (Table 4 ). The transfection activity in this system was dependent upon the presence of free P123. Little activity was observed with the P123-g-PEI(2K) alone (data not shown). However, when the free P123 was added at P123:P123-g-PEI(2K) ratio 1:1 (wt) and higher, the luciferase signals drastically increased. It is noteworthy that luciferase signals were not increased when naked DNA or DNA complexes formed with PEI (25 kDa) were formulated with free P123 (data not shown). Optimal transfection efficacy was achieved at P123:P123-g-PEI(2K) ratio of 9:1 (wt). As is shown in Figure 5 , this system revealed no or very little serumdependency. Also, no cytotoxic effects were observed with the P123-g-PEI(2K) systems at the concentrations examined. For example, Figure 6 shows transfection Gene Therapy using P123-g-PEI(2K) and Superfect systems as a function of the amount of plasmid DNA added per well (N/P ratio was fixed at 16). Upon increase in the DNA amount, Superfect mediated transfection first reaches maximum (at 4 g per well) and then rapidly decreases. This appears to be due to a cytotoxic effect of Superfect, which was visually observed by cell detachment and loss. Indeed the cytotoxicity assay using MTT suggests that following treatment with the Superfect system cell survival decreases by approximately 30% when the amount of DNA increases from 4 g per well to 20 g per well.
In contrast, application of the P123-g-PEI(2K) system resulted in a steady increase of gene expression for all DNA amounts examined ( Figure 6 ). No visual cytotoxicity signs and no decrease in cell viability were observed under these conditions.
The final in vitro experiment reported here evaluates the stability of the P123-g-PEI(2K) formulation with the plasmid DNA. The P123-g-PEI(2K) complexes were prepared and then incubated either at 4°C or −20°C for 5 days before the transient transfection experiment. As is shown in Figure 7 neither incubation regimes were detrimental to the P123-g-PEI(2K) complexes. Formulation kept at −20°C exhibited consistently lower signals compared with formulation kept at 4°C, which may be due to the aggregation of the complex induced by freezing typical for colloidal dispersions. At the same time the luciferase signals obtained with these complexes following the incubation were comparable to those obtained when freshly prepared Superfect complexes were applied to the cells. Therefore, the P123-g-PEI(2K) system revealed both high transfection activity and stability in vitro. The levels of transgene expression using this system at optimal conditions were in the range of 600 to 1500 of ng of luciferase per mg cell protein (Figures 5 and 7) , which compares well with expression levels reported in the literature using other non-viral vectors for gene delivery, such as cationic lipids. 9, 20 This system was further examined in in vivo transfection experiments.
Transfection using the P123-g-PEI(2K) system in vivo
The P123-g-PEI(2K) system was examined in vivo using a protocol previously described for the 1,2-bis(oleoyloxy)-3-(trimethylammonio)propane:cholesterol (DOTAP:Chol) transfection system. 21 The complexes were formulated by combining pCMV-luc plasmid with P123-g-PEI(2K) at the N/P ratio 16 and P123:P123-g-PEI(2K) ratio 9:1 (wt). The DOTAP:Chol and homopolymer PEI (25 kDa) transfection systems that were reported earlier to be effective in vivo were used this study for the references. 5, 21 These complexes were administered in the tail vein of C57Bl/6 mice at 50 g DNA per mice. Lethal effects were not observed with any of the three transfection systems at the examined doses. As is shown in Figure 8 , all three systems produced significant levels of luciferase gene expression in mouse tissues 24 h following administration. However, the levels of tissue distribution of luciferase expression in mice injected with the P123-g-PEI(2K) formulation were distinct from those observed with both DOTAP:Chol and PEI (Figure 8 ). For example, in the case of PEI formulation, luciferase expression in lung was 0.3 ng/mg, while expression in liver, heart and spleen was much less: approximately 0.05 ng/mg in liver, 0.04 ng/mg in heart, and 0.09 ng/mg in spleen. In contrast, administration of the P123-g-PEI(2K) formulation resulted in luciferase expression at the levels of 0.3 ng/mg in liver, 0.13 ng/mg in heart, 0.2 ng/mg in spleen and only 0.15 pg/mg in lung.
Using a novel DOTAP-protamine liposome based gene transfer system, Li and Huang 22 reported luciferase expression at the levels of approximately 0.1 ng/mg in liver, 0.06 ng/mg in heart, 2 ng/mg in spleen, and 7 ng/mg in lung 24 h following i.v. administration in CD-1 mice. To compare our results with the literature we used cationic lipid formulation DOTAP:Chol as an internal control in in vivo gene transfer experiments. As it is seen in Figure 8 following administration of DNA formulated with DOTAP:Chol the levels of luciferase expression were approximately 0.03 ng/mg in liver, 0.31 ng/mg in heart, 0.01 ng/mg in spleen and 1.1 ng/mg in lung. This transgene expression pattern is similar to that described in the original work on DOTAP:Chol by Templeton et al. 21 Compared with this formulation the P123-g-PEI(2K)-based system exhibited 10 times increased gene transfer in liver and 20 times increased gene transfer in spleen. Furthermore, the liver to lung ratio in gene expression using this formulation was 2 compared with 0.027
Figure 7 Evaluation of stability of pCMV-luc/P123:P123-g-PEI(2K) transfection system. pCMV-luc formulated with P123:P123-g-PEI(2K) mixture (9:1 (wt)) was kept at either 4°C (white bars) or −20°C (black bars) for 5 days and then used to transfect Cos-7 cells for 4 hours at 37°C in the presence of serum. Transfection was carried out at 1.5 g of pCMV-luc per well. The transfected cells were allowed to rest an extra 16 h, and then harvested for the measurement of the luciferase activity. Transfections using pCMV-luc plasmid formulated with Superfect and naked DNA are shown for comparison. All transfection experiments were carried out with serum.
Figure 8 Tissue distribution of luciferase expression after i.v. administration in mice of pCMV-luc formulated with DOTAP:Chol (white bars), PEI (25 kDa) (shaded bars) or P123:P123-g-PEI(2K) mixture (black bars). pCMV-luc formulated with the corresponding transfection system as described in Materials and methods was injected in the tail
Gene Therapy observed for DOTAP:Chol system and 0.014 reported for DOTAP-protamine liposome system. 21, 22 Therefore, administration of the P123-g-PEI(2K) formulation resulted in a more even distribution of the expressed gene in liver, heart, lungs and spleen and higher transgene expression in liver when compared with PEI or lipid compositions.
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Discussion
This work reports the synthesis and characterization of a series of cationic copolymers on the basis of the conjugates of PEI with PEO or Pluronic P123. The initial objective underlying the development of cationic copolymers, such as PEO-based block or graft copolymers, was to increase solubility of the polycation-DNA complexes. 23 This approach was used, for example, with antisense oligonucleotides to produce stable complexes dispersed in aqueous media that revealed high activity in regulating gene expression in in vitro and in vivo studies. 7, 14, 15 Also, the formation of dispersed complexes from plasmid DNA and PEO-modified poly-l-lysine has been well documented. 8, 10, 12 However, there is relatively little data on the transfection activity of these systems in vitro, 8, 12 and we are not aware of any paper reporting performance of these systems in vivo. Furthermore, PEO-poly-l-lysine copolymers do not provide an optimal model for evaluating the effects of PEO-modification on the transfection activity of the DNA interpolyelectrolyte complexes, since DNA complexes with poly-l-lysine alone have very low transfection efficacy. 24, 25 In contrast, PEI represents one of the most efficient non-viral transfection agents that is currently reported for both in vitro and in vivo applications, which provides a good reference point for evaluating the effects of polycation chain modification on gene transfer. 4, 5 The results of the present work clearly show that by modifying PEI with PEO chains, polycation/DNA complexes can be obtained that are highly stable in aqueous dispersions, even upon complete neutralization of charge. It is noteworthy that these complexes were stable in a variety of solutions including PBS, HBS and DMEM with and without serum. This is an obvious improvement compared with the PEI homopolymers, which form with DNA either insoluble complexes or soluble complexes that are highly sensitive to the media composition. 26 Improved solubility of the complexes formed by PEOgrafted PEI is due to the effect of the hydrophilic PEO chains. In such systems, the ammonium groups of the PEI bind to the DNA phosphate groups, resulting in the formation of micelle-like species with a hydrophobic core from the neutralized DNA and PEI chains and a hydrophilic corona from PEO segments. 23 The complexes are electroneutral when the concentration of ammonium groups equals the concentration of the phosphate groups. There is no or little incorporation of the excess of the polycation component into the complex beyond the neutralization point. This is striking in comparison with the homopolymer PEI, which exhibits strong positive charge at high N/P ratios. 24 Most likely, in the case of the PEOgrafted PEI, incorporation of excess of copolymer into the complex is prevented by steric repulsion of the PEO chains. The observed low sensitivity to added salts is probably explained by the electroneutrality of the complexes. In contrast, complexes formed by homopolymer PEI (25 kDa) at high N/P ratios contain a charged polycation 'corona' surrounding the neutralized polycation/DNA 'core'. 27 Interactions of the low molecular mass electrolytes and serum proteins with the polycation corona can affect the stability of these systems in aqueous dispersion. Furthermore in the case of the PEOmodified polycations the size and stability of the particles did not depend on the order of mixing of the DNA and polycation components and serum (data not shown). In contrast, in the case of PEI (25 kDa) particle size was very sensitive to the mixing order of the DNA and polycation components both with and without serum.
Aside from higher stability in dispersion, PEO modification of PEI results in a significant decrease in the transfection activity of the DNA complexes. This result is in line with the observation by Kim's group, who reported that the transfection activity of the PEO-g-poly(llysine)/DNA complexes decreased as the degree of grafting of the poly(l-lysine) with PEO chains was increased. 12 Indeed, the complexes formed by PEO-grafted PEI (25 kDa) exhibited only a fraction of the activity observed with the non-modified PEI, and the activity of the copolymer was abolished at higher modification degrees. Also, although PEO-modification of the PEI (2 kDa) resulted in an obvious improvement in the solubility of the complexes compared with the non-modified PEI (2 kDa) system, the transfection activity remained very low. There are at least two possible reasons for such an effect. First, PEO chains, which are well known to sterically hinder the interaction of polymers and liposomes, may also hinder the interaction of the copolymer/DNA complexes with the cells. Second, at least some of the complexes formed by PEO-grafted low molecular PEI appear to be very large and rigid from electron microscopy studies, which may prevent entry into cells.
The P123-modified PEI was the only copolymer that revealed consistently high transfection activity in our studies. P123 belongs to a class of polymeric surfactants, which possess the ability to interact with biological membranes and enhance transport of many biologically active compounds into the cell. 17 Therefore, we conjugated this copolymer with PEI to improve interaction of complexes with cell membranes. Complexes formed with P123-modified PEI and DNA appear to be quite structurally distinct from those formed by the PEO-grafted PEI. The P123-g-PEI(2K) systems are less stable in dispersion, which is probably due to the effect of the insoluble PPO chains in the P123 moiety. At the same time, they can be stabilized in dispersion by addition of excess P123, which is indicative of the self-assembly and solubilization behavior typical of the aqueous solutions of the Pluronic block copolymers. 28 Remarkably, at these conditions of the high colloidal stability, high transfection activity is observed. Both copolymer components, the P123-grafted PEI and free P123, appear to be essential for the high transfection activity of this system, because when formulated with the DNA separately, these components do not improve the transfection. Furthermore, in the absence of the PEI, P123 does not affect the transfection activity of the DNA complex with PEI homopolymer. There was some dependence on the order of adding of the block copolymer components: the luciferase expression was the same or even slightly increased when corresponding amount of P123 was first added to the cells for 10-15 min followed by addition of the DNA and P123-g-PEI(2K) complex (data not shown). This result also means that the block copolymer components do not have to be formulated with the DNA simultaneously, but need to be present together in the transfection media within some time interval.
It is possible that P123-grafted PEI serves as a 'binding agent', providing for the self-assembly of DNA and block copolymers into the transfection complexes. Aggregates formed by Pluronic block copolymers are known to easily self-assemble and dissociate into individual components, which can rapidly cross the biological membranes and penetrate into the cell. 17 While the mechanisms of the cell transport and transfection with the DNA-P123-g-PEI(2K) systems require further investigation, we hypothesize that these transfection complexes fuse with the cell membrane, resulting in the efficient penetration of the DNA into the cell. Previous study by Liu et al 29 used hydrophilic Pluronic F68 and F127 to prepare emulsions of cationic lipids for gene transfer. It is noteworthy, that the transfection levels using these formulations did not depend on the presence of serum in the cell culture media which can be related to the apparent absence of serum dependency in the case of P123-g-PEI(2K) and P123 mixture reported in this work. However, based on the dependence on the order of adding of the block copolymer components discussed earlier in our work it is also possible that aside from improving the stability of the dispersion the role of free P123 includes some effects on the cells enhancing transgene expression. Improvements in gene expression were reported in smooth muscle cells in the presence of Pluronic F127 using adenoviral vectors, 30 and in fibroblasts (NIH 3T3) in the presence of Pluronic P85 using poly(N-ethyl-4-vinylpyridinium bromide) as the gene transfer agent. 18 Further study of the mechanisms of the phenomena underlying potentially important effects of Pluronic block copolymers on gene transfer is needed.
The P123-g-PEI(2K)-based transfection system was active not only in vitro, but revealed high transfection activity in in vivo experiments. The tissue distribution of the gene expression observed with this system was notably different from those for the cationic liposomes and PEI homopolymer complexes. Both DOTAP:Chol and PEI are most efficient in transfecting lungs, while, in the case of the P123-g-PEI(2K) system, proportionally higher transfection of other organs was observed. Also, one interesting and potentially important observation is that significant level of luciferase expression was in the liver. The hepatic tissue is known to accumulate 60% of the dose of plasmid DNA formulated with various cationic liposomes (Lipofectin, LipofectACE) after i.v. administration as demonstrated by Mahato et al. 31 At the same time, the level of gene expression per microgram of DNA taken up per tissue is a thousand fold lower in liver than in lung, as demonstrated by Liu et al 32 using DNA/cationic liposome mixtures. It has been hypothesized that decreased gene expression in the liver is due to the rapid degradation of DNA following phagocytosis of the DNA:cationic liposome complex in the Kupffer cells. 31 The particles P123-g-PEI(2K)-based complexes used in the in vivo transfection experiment are 110 nm in diameter, which is smaller than the sizes reported for either DNA/PEI complexes (Ͻ100 m) 5 or DNA/DOTAP:Chol complexes (200 to 400 nm). 21 It is possible that smaller complexes generated with the P123-g-PEI(2K) system may avoid or prevent phagocytosis by scavenger cells in liver allowing higher transfection activity of this system in liver tissue. Thus, this system may potentially be used for gene delivery to the liver.
Gene Therapy 
Synthesis of activated polyethers
The free terminal hydroxy group of the methoxy-PEO, 5 kDa, and P123 were activated by 1,1Ј-carbonyldiimidazole for subsequent conjugation with polycations using modified potocol. 11 Briefly, 1 mmol of methoxy-PEO or 0.5 mmol P123 were dried by co-evaporation with anhydrous acetonitrile and then reacted with either 3 mmol (methoxy-PEO) or 0.3 mmol (P123) of 1,1Ј-carbonyldiimidazole in anhydrous acetonitrile. The reaction mixture was agitated for 3 h at 40°C and then diluted with the same volume of water. The solution was dialyzed twice against 50% ethanol using Membra-Cel MD-25-03.5 (Applied Technologies, Chicago, IL, USA), and the solvent was then removed in vacuo. Activated methoxy-PEO and P123 were obtained with quantitative yield.
Conjugation of PEO with low molecular mass PEI
The synthesis and characterization of PEO(8K)-g-PEI(2K) was reported previously. 11 To synthesize PEO(10K)-g-PEI(2K), 0.5 mmol methoxy-PEO-glycidyl ether were reacted with 2.5 mmol of PEI, 2 kDa, in 30 ml of 0.2 m carbonate buffer, pH 8.0. After 24 h the reaction mixtures were dialyzed twice against 10% ethanol using MembraCel MD-25-03.5 and then lyophilized. The yield of the PEO(10K)-g-PEI(2K) was 80%. Both PEO(8K)-g-PEI(2K) and PEO(10K)-g-PEI(2K) samples did not contain free PEI and contained less than 10% (wt) of free PEO as determined by gel permeation HPLC using SigmaChrom GFC-100 column (7.5 × 300 mm).
Conjugation of PEO with high molecular mass PEI To synthesize conjugates of PEO and high molecular mass PEI, 25 kDa, 1,1Ј-carbonyldiimidazole-activated methoxy-PEO was reacted with PEI in 0.2 m carbonate buffer, pH 8 for 24 h at room temperature. To obtain copolymers with different degrees of substitution various excesses of PEO chains with respect to primary amino groups of PEI were used: 25% resulting in PEO(5K) 37 -g-PEI(25K) and 75% resulting in PEO(5K) 61 -g-PEI(25K). The reaction products were dialyzed as described above and precipitated into diethyl ether. The yields of PEO(5K) 37 -g-PEI(25K) and PEO(5K) 61 -g-PEI(25K) were approximately 50%. Neither product contained free PEI and contained 50% (wt) of free PEO, which was separated by gel permeation HPLC.
Conjugation of P123 with low molecular mass PEI To synthesize P123-g-PEI(2K), 0.5 mmol of 1,1Ј-carbonyldiimidazole-activated P123 were reacted with 2.5 mmol of PEI, 2 kDa, in 30 ml of 0.2 m carbonate buffer, pH 8.0. After 24 h the reaction mixture was dialyzed twice as described above and then lyophilized. The yield of P123-g-PEI(2K) was 65%. This sample did not contain free PEI and contained 10% (wt) of free P123 as determined by gel permeation HPLC analysis.
Molecular mass determination by GPC-light scattering Weight average molecular masses (M w ) and polydispersity indexes (M w /M n ) were determined by GPC on TSK gel G3000PW XL column (TosoHaas, Montgomeryville, PA, USA) connected with a multiangle light scattering detector (DAWN-F laser photometer, Wyatt Technology, Santa Barbara, CA, USA) and a differential refractive index detector (Wyatt/Optilab 903 interferometric refractometer) operating at 632.8 nm. An aqueous solution of 50 mm sodium chloride was used as a mobile phase at 0.5 ml/min flow rate. Before the specific refractive index increments (dn/dc) measurements the samples were dialyzed for at least 1 day in 0.05 m NaCl using the membrane with the 3500 Da cutoff.
Molecular mass determination by GPC Molecular mass of P123-g-PEI(2K) was determined by GPC analysis (M GPC ) using the SigmaChrom GPF-1300 column and 20% ethanol in 50 mm ammonium acetate buffer, pH 7.0 as a mobile phase. The column was calibrated using PEO (Shearwater Polymers, Huntsville, AL, USA), PEI (Monomer-Polymer Dajac Laboratories, Feasterville, PA, USA) and Pluronic block copolymers (BASF) with the MW ranging from 2 kDa to 50 kDa.
Polyether and PEI ratio
The ratio of PEO (or P123) and PEI in the copolymer samples was determined from 1 H-NMR spectra using integral values obtained for the -CH 2 CH 2 O-protons of PEO and -CH 2 NH-protons of PEI. Before NMR measurements all copolymers were purified from admixtures of non-conjugated polyethers by preparative thin layer chromatography on Silicagel using dichloromethanemethanol mixture (6:4) for elution.
Determination of the nitrogen groups
The total content of the nitrogen in the copolymers was determined by elemental microanalysis. The ratios of primary, secondary and tertiary amino groups were determined from 1 H-NMR spectra. The amount of ionizable groups in polycations and the degrees of ionization at a given pH were determined by potentiometric titration.
Plasmid DNA Two luciferase encoding plasmids, pGL3, 5.2 kb under control of the SV-40 promoter, and pCMV-luc, 7.2 kb, under the control of the CMV promoter were used in this work. Both plasmids were expanded in DH5␣ E. coli and were prepared using Qiagen endotoxin-free plasmid Giga-prep kits according to the supplier's protocol. The quantity and quality of the purified plasmid DNA was assessed by spectrophotometric analysis at 260 and 280 nm as well as by electrophoresis in 1% agarose gel. Purified plasmid DNA were resuspended in sterile saline (Gibco-BRL) and frozen in aliquots at a concentration of 5 mg/ml. pGL3 was used in physicochemical characterization and in vitro transfection studies, pCMV-luc was used in in vitro and in vivo transfection experiments.
Preparation of complexes of DNA and cationic copolymers for in vitro studies The complexes were prepared by adding drop-by-drop the stock solutions of the cationic copolymers to the solutions of the plasmid DNA in 10 mm phosphate buffer, 10 mm Hepes buffer, PBS (phosphate-buffered saline) or HBS (Hepes-buffered saline), or DMEM (Dulbecco's modified Eagle medium containing 10 mm Hepes buffer) all pH 7.4, to obtain systems with given DNA concentrations and N/P ratios. In select experiments the complexes formed between P123-g-PEI(2K) and plasmid DNA were further supplemented with the solutions of P123. All solutions of copolymers, DNA and complexes were filtered through a 0.2 m filter.
Turbidity measurements
The measurements of turbidity () were carried out using a Shimadzu UV 160 1PC spectrophotometer at 420 nm following mixing and equilibration of the sample solutions. In all experiments the concentration of the plasmid DNA in solution was 0.2 mg/ml. Polycations were added to DNA at various N/P ratios. Turbidity data are reported as = (100 − T)/100 where T is the transmittance (%).
Agarose gel electrophoresis DNA complexes were analyzed by electrophoresis in a 0.8% agarose gel with 0.04 m Tris-acetate buffer, pH 7.4 containing 1 mm EDTA, at 60 V for 90 min. DNA was visualized by UV illumination following staining of gels with ethidium bromide (0.5 g/ml) for 20 min at room temperature.
Zeta potential and particle size measurements
The electrophoretic mobility measurements were performed at 22°C using a 'ZetaPlus' Zeta Potential Analyzer (Brookhaven Instrument) with 15 mV solid state laser operated at a laser wavelength of 635 nm. The -potential of the particles was calculated from the electrophoretic mobility values using the Smoluchowski equation. The effective hydrodynamic diameter was measured by photon correlation spectroscopy using the same instrument equipped with the Multi-Angle Option at 22°C at an angle of 90°.
Electron microscopy
For the negative staining electron microscopy experiments, 10 g of pGL3 plasmid, or its complexes with corresponding copolymer were prepared in 250 l of 20 mm Hepes buffer, pH 7.4. Then, a drop of the sample solution was allowed to settle on a Formvar precoated grid for 1 min, the excess sample was wicked away with filter paper and a drop of staining solution (1% uranyl acetate) was allowed to contact the sample for 1 min. The samples were analyzed using a Philips 410 TEM microscope.
In vitro transfection
Cos-7 cells were seeded at 7 × 10 5 per well in 12-well plate (Costar) 24 h before transfection (70% confluent at transfection). Three micrograms of pCMV-luc or pGL3 were formulated with the different polymers at various N/P ratios or with Superfect (Qiagen, Valencia, CA, USA; lot No. BGI003/29) according to Qiagen's recommendation. Briefly, for the polymers, the transfection mixture was prepared as follows: 30 l of DNA (0.1 mg/ml) and 35 l of polymer (to obtain appropriate N/P ratios) were added to an Eppendorf tube containing 100 l of DMEM with 1% Hepes. For the Superfect compositions, 3 g of plasmid DNA in 100 l of serum-free DMEM were supplemented with 15 l of the Superfect solution. The transfection mixtures were vortexed for 10 s, incubated for 5 min and then diluted to 1 ml with DMEM (1% Hepes, 1% penicillin-streptomycin, with or without 10% FBS). Immediately before transfection cells were washed once with PBS, and then 500 l of the transfection mixture were added per well. Cells were transfected for 4 h at 37°C (5% CO 2 ), rinsed with PBS, allowed to rest overnight in 1 ml of complete DMEM (10% FBS, 1% Hepes, 1% penicillin-streptomycin) and then harvested. Luciferase assay was performed according to Promega's recommendation. Briefly, cells were lysed in 350 l of 1 × CCLR on ice for 30 min and then centrifuged at 13 000 g for 2 min. Supernatants were collected and analyzed for luciferase activity. In a typical experiment 20 l of supernatant was added to luminometric tubes containing 100 l of luciferase substrate (Promega). Light emission was measured with a luminometer (Berthold) for a period of 5 sec. The relative light units/s determined in 20 l of cell extract were converted into the amount of luciferase (pg) using a luciferase standard curve. The standard curve was obtained by diluting known amounts of recombinant luciferase (Promega E1701) in lysis buffer used to extract the cells. The amount of cell protein in 20 l of cell extract was determined using BiCinchonic Acid assay kit and bovine serum albumin (Sigma) as a positive control. The data was reported as means ± s.e.m. in pg of luciferase normalized for g of cell protein. The cytotoxicity was assessed following cell exposure to various transfection systems using a standard MTT (3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide) assay. 33 In vivo transfection All solutions used for in vivo transfection experiments were prepared in bidistilled water containing 5% dextrose ('DW5 solution'). The P123:P123-g-PEI(2K) mixture was prepared as follows: 200 g of pCMV-luc in 440 l of DW5 solution was first mixed with 36 l of 100 g/l of P123-g-PEI(2K) in DW5 solution and then mixed with 324 l of 100 g/l P123 in DW5 solution. The mixture with PEI was prepared as follows: 240 g of PEI in 400 l of DW5 solution was added to 200 g of pCMV-luc in 400 l of DW5 solution. The DOTAP:cholesterol mixture was prepared as follows: 200 g of pCMV-luc in 400 l of DW5 solution was added to 400 l of DW5 solution containing the DOTAP:Chol transfection reagent at a total lipid concentration of 8 mm. The DOTAP:Chol transfection reagent was a gift from Quantum Biotechnologies (Montreal, PQ, Canada). After gentle mixing, the transfection systems were allowed to incubate at room temperature for 30 min and then 200 l of the mixtures were injected i.v. into the tail vein of C57Bl/6 (6-8-week-old) female mice (50 g DNA per mice).
The animals were kept in groups of four and fed ad libitum. Twenty-four hours after injection the mice were killed, major organs (liver, heart, lungs, spleen, kidney Gene Therapy and brain) collected and rapidly homogenized with a polytron in cell lysis buffer (Promega) supplemented with protease inhibitor cocktail (Sigma, St Louis, MO, USA; cat No. P8340). The extracts were assessed for luciferase activity as described above. The data was reported as means ± s.e.m. in relative light units per second and normalized for protein concentration measured using the BiCinchoninic Acid assay kit (Sigma).
